New Weight-Loss shot tested in humans for first time
NCT ID NCT06737536
First seen Sep 30, 2025 · Last updated Jun 11, 2026 · Updated 32 times
Summary
This early-stage study tested a new medicine called NNC0662-0419 in 100 adults with overweight or obesity. The goal was to see if it is safe and how the body handles it. Participants received either the study drug or a placebo as an injection under the skin. The study lasted about 9 months and was the first time this medicine was given to humans.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Celerion, Lincoln
Lincoln, Nebraska, 68502, United States
Conditions
Explore the condition pages connected to this study.